U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...
(Reuters) -Shares in European vaccine makers fell on Friday after U.S. President-elect Donald Trump picked Robert F. Kennedy ...
Medpage Today on MSN16h
Big Blow to Anticoagulation Strategy Against Afib-Related Cognition ProblemsCHICAGO -- Researchers failed to prevent cognitive impairment in people with existing atrial fibrillation (Afib) by going the ...
15hon MSN
Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...
The trial met both primary endpoints, with tirzepatide showing a 38% decrease in heart failure outcomes compared to placebo.
U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...
In today's biotech news, Zepbound trial data, Regenxbio's Duchenne muscular dystrophy treatment, and Intellia's promising ...
The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...
Robert F. Kennedy Jr. would have broad power as HHS secretary to strip vaccine makers' protections against lawsuits ...
Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...
The drugmaker Ely Lilly ( LLY -4.93%) has had a very successful run over the long run. Shares currently trade around $818 and are up 20,030% over the past 40 years. The stock has also performed well ...
Doctors say they have not seen anything like this since the emergence of statins to lower cholesterol. But do we know enough ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback